Medicinal extract for preventing and treating diabetes and application thereof
An extract and diabetes technology, applied in the field of medicine, can solve the problems of prevention and treatment of type 2 diabetes drugs or health care products that have not been reported, and achieve high development prospects, simple extraction process, and significant hypoglycemic activity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0033] Preparation of Quezui Tea Extract.
[0034]Quezui tea was harvested from Wuding County, Yunnan Province. After processing, 1.7kg dried Quezui tea was obtained. It was extracted 3 times with 10 times hot water for 30 minutes each time. The filtrate was combined to obtain 20.8L, and the remaining Quezui tea residue was extracted with ethanol. 3 times, 2h each time, to obtain Quezui tea ethanol extract m 0 . 20.8L water extraction filtrate was concentrated to 12.6L, after D 101 Gradient elution of polystyrene macroporous adsorption resin, of which 100% of the water washing is the extract of Quezui tea m 1 , 25% ethanol eluate is Quezui tea extract m 2 , 100% ethanol eluate is Quezui tea extract m 3 .
Embodiment 2
[0036] A 3T3-L1 adipocyte insulin resistance model was established to observe the effect of Quezui tea extract on glucose uptake in 3T3-L1 adipocytes.
[0037] 1. Induction and differentiation of 3T3-L1 cells
[0038] 3T3-L1 preadipocytes were placed in High glucose DMEM (10% newborn calf serum) at 37°C, 5% CO 2 cultured in a carbon dioxide incubator. After the cells grow and fuse, add 0.5mM IBMX, 1×10 -3 mg·L-1 insulin, 1×10 -3 mM dexamethasone, 1×10 -2 High glucose DMEM (10% fetal bovine serum) in mM rosiglitazone was cultured for 72h; then replaced with 1×10 -3 High glucose DMEM (10% fetal bovine serum) containing mg·L-1 insulin was further cultured for 24h. The successfully differentiated 3T3-L1 adipocytes became larger in size, and cyclic lipid droplets were aggregated around the nucleus.
[0039] 2. Experimental grouping and administration
[0040] The induced differentiated 3T3-L1 adipocytes were collected, digested with 1‰ collagenase-0.25% trypsin solution to c...
Embodiment 3
[0053] Detection of the inhibitory effect of Quezui tea extract on α-glucosidase.
[0054] The sparrow tea extract m 0 , m 1 , m 2 , m 3 The final concentrations after administration were 100, 50, 25, 12.5, 6.25, 3.125, 1.5625, 0.7813, 0.3906, 0.1953 μg / mL with PBS, respectively. Before the experiment, 10 μL of different concentrations of sample solutions and 50 μL of α-glucosidase solution (0.1 U / mL) were added to 100 μL of phosphate buffer (0.1 M), and incubated at 37 °C for 15 min. Immediately after the pre-incubation, 40 μL of 4-nitroα-D glucopyranoside (PNPG, 5 mM) was added and incubated at 37° C. for 60 min. After incubation with 50 μL Na 2 CO 3 The solution (0.1M) terminated the reaction, the OD value of the sample was measured at 405nm, and the α-glucosidase inhibition rate of each group of samples was calculated according to formula 1. Taking drug-free PBS as a blank control (adding the same amount of DMSO solution), three sub-wells were set for each group of ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com